CINECA IRIS Institutional Research Information System

CAPPAGLI, VIRGINIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.740
AS - Asia 1.987
EU - Europa 1.895
SA - Sud America 323
AF - Africa 137
OC - Oceania 7
Totale 8.089
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.644
SG - Singapore 615
IT - Italia 585
CN - Cina 579
DE - Germania 385
HK - Hong Kong 304
BR - Brasile 261
SE - Svezia 258
VN - Vietnam 193
GB - Regno Unito 147
BG - Bulgaria 104
AT - Austria 92
FR - Francia 87
CI - Costa d'Avorio 64
CA - Canada 63
IN - India 61
JP - Giappone 55
RU - Federazione Russa 54
FI - Finlandia 47
TR - Turchia 41
SN - Senegal 28
BD - Bangladesh 27
NL - Olanda 25
AR - Argentina 23
MA - Marocco 21
PL - Polonia 20
MX - Messico 18
IQ - Iraq 15
ZA - Sudafrica 14
CZ - Repubblica Ceca 12
KR - Corea 11
PK - Pakistan 11
EC - Ecuador 10
ID - Indonesia 10
UZ - Uzbekistan 10
CO - Colombia 9
ES - Italia 9
GR - Grecia 9
PH - Filippine 9
SA - Arabia Saudita 9
CH - Svizzera 7
TW - Taiwan 7
UA - Ucraina 7
VE - Venezuela 7
EE - Estonia 6
RO - Romania 6
AU - Australia 5
DO - Repubblica Dominicana 5
IL - Israele 5
LT - Lituania 5
AL - Albania 4
AZ - Azerbaigian 4
CL - Cile 4
DK - Danimarca 4
IE - Irlanda 4
KE - Kenya 4
PT - Portogallo 4
PY - Paraguay 4
BE - Belgio 3
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
JO - Giordania 3
MY - Malesia 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
EG - Egitto 2
GT - Guatemala 2
LB - Libano 2
MC - Monaco 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BH - Bahrain 1
BO - Bolivia 1
DZ - Algeria 1
ET - Etiopia 1
HR - Croazia 1
KI - Kiribati 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
QA - Qatar 1
Totale 8.089
Salva come PNG Salva come JPEG
Città #
Ashburn 445
Dallas 380
Singapore 341
Hong Kong 299
San Jose 271
Chandler 245
Fairfield 211
Santa Clara 208
Milan 187
Houston 162
Woodbridge 156
Shanghai 120
New York 109
Beijing 106
Seattle 102
Sofia 102
Wilmington 85
Vienna 84
Los Angeles 78
Cambridge 73
Munich 71
Abidjan 64
Ho Chi Minh City 61
Ann Arbor 58
Boardman 55
Pisa 55
Princeton 54
London 50
Florence 49
Frankfurt am Main 45
Rome 44
Tokyo 41
Lauterbourg 40
Lawrence 40
Serra 36
Council Bluffs 32
Redmond 32
São Paulo 30
Medford 29
Dakar 28
Hanoi 25
Ottawa 24
Buffalo 22
Bremen 21
Redondo Beach 19
Dong Ket 18
Helsinki 18
Boulder 17
Denver 17
Hefei 17
Tianjin 17
Atlanta 16
Montreal 16
Redwood City 16
Casablanca 15
Des Moines 15
Istanbul 15
San Diego 15
Turku 15
Dearborn 14
Warsaw 14
Boston 13
Phoenix 12
Washington 12
Belo Horizonte 11
Nuremberg 11
Orem 11
Amsterdam 10
Bengaluru 10
Chicago 10
Chiesina Uzzanese 10
Fuzhou 10
Lancaster 10
Baghdad 9
Columbus 9
Guangzhou 9
Haiphong 9
Johannesburg 9
Paris 9
Rio de Janeiro 9
Tashkent 9
Toronto 9
Ankara 8
Brooklyn 8
Dhaka 8
Düsseldorf 8
Ogden 8
Poplar 8
Scandicci 8
Seoul 8
Brno 7
Hangzhou 7
Izmir 7
Lucca 7
Nanjing 7
Stockholm 7
Cascina 6
Chengdu 6
Fortaleza 6
Jiaxing 6
Totale 5.385
Salva come PNG Salva come JPEG
Nome #
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 244
Medullary thyroid cancer treated with vandetanib: predictors of longer and durable response 241
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer 234
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 234
Targeted Therapy in Thyroid Cancer: State of the Art 224
Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib 217
Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations 214
Protein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life 209
Next generation sequencing revealed RET or RAS mutation in medullary thyroid cancer that were negative at sanger sequencing 205
Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre 196
GENETIC SCREENING OF RET CAN IDENTIFY NEW MUTATIONS EVEN AFTER 20 YEARS 194
Il carcinoma tiroideo: nuove prospettive terapeutiche. 191
AFTER 20 YEARS, RET GENETIC SCREENING STILL INDENTIFIES NEW GERMILINE AND SOMATIC MUTATIONS 188
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 182
Thyroid cancers: From surgery to current and future systemic therapies through their molecular identities 178
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 177
Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma 173
Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT) 172
Lenvatinib treatment in the real clinical practice of progressive, radioiodine-refractory differentiated thyroid carcinoma: analysis of a big series followed in a single center 170
GENETIC LANDSCAPE OF SOMATIC MUTATIONS IN A LARGE COHORT OF SPORADIC MEDULLARY THYROID CARCINOMAS STUDIED BY NEXT GENERATION TARGETED SEQUENCING 164
Systemic treatment of advanced, metastatic, medullary thyroid carcinoma 164
MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children 162
New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations 161
No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH 161
OR21-01 Pre-Operative Calcitonin Value as a Predictive Factor of Cancer Related Death in Sporadic Medullary Thyroid Carcinoma 156
Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment 155
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma 155
Body Mass Index and Sporadic Medullary Thyroid Cancer: Insights from a Large Series 151
Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone 145
After 20 Years, RET genetic screening still identifies new germline and somatic mutations 141
Calcitonin receptor expression in medullary thyroid carcinoma 137
Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer 137
Cabozantinib: An orphan drug for thyroid cancer 136
RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency 130
Chylous effusions in advanced medullary thyroid cancer patients treated with selpercatinib 129
Ret mutated C-cells proliferate more rapidly than non-mutated neoplastic cells 129
Proteinuria is a late-onset adverse event in patients treated with cabozantinib 128
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center 128
The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma 126
The Integrity of Tumor Capsule Identifies a Subgroup of Indolent Cases Not Only Among the Follicular (FVPTC) But Also in Classic Variant of Papillary Thyroid Cancer (CVPTC) 124
Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response 119
MON-537 Primary Adrenal Insufficiency During Tyrosine Kinase Inhibitors Treatment in Advanced Thyroid Cancer Patients 117
null 114
Non thyroidal second primary malignancies in differentiated thyroid cancer patients: is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence? 113
Hypothesizing a role of ret hyperactivation on weight control in patients with type 2A multiple endocrine neoplasia (MEN2A) 111
Clinical Management of a Patient with a Locally Recurrent Medullary Thyroid Cancer and Asymptomatic Slowly Progressing Distant Metastasis. 102
The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 Years experience at one single center 100
Hand-foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer 97
MULTIFOCALITY AND BILATERALITY IN MEDULLARY THYROID CANCER: BASIS FOR A PROOF-OF-CONCEPT SAFETY OF LOBECTOMY 94
Pre-surgical Value Of Basal Calcitonin Is Not Predictive Of Central Neck Compartment Metastases. 93
Predictive factors for central neck compartment lymphnodes metastases' in sporadic medullary thyroid cancer patients 89
null 58
Fifty Years after the First Description, MEN 2B Syndrome Diagnosis Is Still Late: Descriptions of Two Recent Cases 54
Genetic origin of multifocal sporadic medullary thyroid cancer and C-cell hyperplasia 49
Comparison of pre-operative calcitonin, FNAC, and ultrasound risk stratification systems in patients with medullary thyroid carcinoma 20
Redefining the prevalence of different clinical variants in MEN2A and their correlation with RET germline mutations: a single-center series and experience 18
Prevalence and genetics of "de novo" MEN2 syndromes 17
Totale 8.227
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.864
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022505 21 15 7 25 100 66 16 20 31 27 43 134
2022/2023956 110 147 76 79 81 106 17 66 180 10 76 8
2023/2024621 59 70 94 55 86 109 22 10 3 5 33 75
2024/20251.702 16 67 22 101 182 150 168 89 162 226 186 333
2025/20262.741 200 398 307 280 288 200 348 130 173 217 100 100
2026/20277 7 0 0 0 0 0 0 0 0 0 0 0
Totale 8.227